Supernus Pharmaceuticals (SUPN) Interest & Investment Income (2011 - 2020)
Supernus Pharmaceuticals (SUPN) reported Interest & Investment Income of $3.3 million for Q3 2020, down 41.32% year-over-year from $5.6 million in Q4 2019, and down 21.42% quarter-over-quarter from $4.2 million in Q2 2020.
Supernus Pharmaceuticals (SUPN) Interest & Investment Income (2011 - 2020) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 10 years of Interest & Investment Income data on file, last reported at $3.3 million in Q3 2020.
- Interest & Investment Income for Q3 2020 came in at $3.3 million, down 41.32% year-over-year; the trailing twelve-month figure through Sep 2020 was $18.4 million (down 8.81% YoY), and the FY2018 annual result was $13.8 million, up 383.34% from the prior year.
- Interest & Investment Income fell to $3.3 million in Q3 2020 per SUPN's latest filing, from $4.2 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.6 million in Q3 2019 and troughed at $327000.0 in Q1 2016.
- A 5-year average of $2.4 million and a median of $1.2 million in 2018 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2018 and 2020: Interest & Investment Income soared 458.54% in 2018, then slumped 41.32% in 2020.
- A 5-year view of Interest & Investment Income shows it stood at $396000.0 in 2016, then jumped by 117.68% to $862000.0 in 2017, then soared by 423.43% to $4.5 million in 2018, then grew by 23.2% to $5.6 million in 2019, then tumbled by 41.32% to $3.3 million in 2020.
- Business Quant data shows SUPN's Interest & Investment Income at $3.3 million in Q3 2020, $4.2 million in Q2 2020, and $5.6 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.60 Bn | 2.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.26 Mn |
| Jun 30, 2020 | 4.15 Mn |
| Sep 30, 2019 | 5.56 Mn |
| Jun 30, 2019 | 5.45 Mn |
| Mar 31, 2019 | 4.68 Mn |
| Dec 31, 2018 | 4.51 Mn |
| Sep 30, 2018 | 4.46 Mn |
| Jun 30, 2018 | 3.66 Mn |
| Mar 31, 2018 | 1.21 Mn |
| Dec 31, 2017 | 862,000.00 |
| Sep 30, 2017 | 814,000.00 |
| Jun 30, 2017 | 656,000.00 |
| Mar 31, 2017 | 531,000.00 |
| Dec 31, 2016 | 396,000.00 |
| Sep 30, 2016 | 378,000.00 |
| Jun 30, 2016 | 365,000.00 |
| Mar 31, 2016 | 327,000.00 |
| Dec 31, 2015 | 262,000.00 |
| Sep 30, 2015 | 169,000.00 |
| Jun 30, 2015 | 137,000.00 |